🇺🇸 FDA
Pipeline program

Casdatifan

PEAK-1

Phase 3 small_molecule active

Quick answer

Casdatifan for Metastatic Clear Cell Renal Cell Carcinoma is a Phase 3 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Arcus Biosciences
Indication
Metastatic Clear Cell Renal Cell Carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials